多发性骨髓瘤中1q21额外拷贝的预后价值取决于原发遗传事件
这项回顾性研究纳入794例多发性骨髓瘤患者,按原发染色体异常分组,分析gain(1q)的临床特征与预后。结果显示gain(1q)与至下次治疗时间短和总生存期(OS)不良相关,且1q21≥4拷贝比3拷贝更差;但在克隆性gain(11q)且无已知原发IGH易位亚组中,3拷贝1q21即预示不良结局,而无gain(1q)者中位OS超过9年。
要点
- gain(1q)与MM患者至下次治疗时间短及OS不良相关。
- 1q21≥4拷贝比3拷贝预后更差,但该差异取决于原发遗传事件。
- 克隆性gain(11q)且无原发IGH易位者中,3拷贝1q21即与不良结局相关。
核心结论
- gain(1q)在全部MM患者中与至下次治疗时间短和OS不良相关。
- 1q21拷贝数增加的预后影响因原发染色体异常亚组而异。
- 克隆性gain(11q)且无已知原发IGH易位者中,3拷贝1q21即与不良结局相关。
研究设计与样本
- 回顾性研究纳入794例多发性骨髓瘤患者。
- 按原发染色体异常定义亚组,分析临床特征与常见染色体异常包括gain(1q)。
主要发现
- 全部组中gain(1q)与至下次治疗时间短和OS不良相关,1q21≥4拷贝比3拷贝影响更差。
- 克隆性gain(11q)且无已知原发IGH易位亚组中,3拷贝1q21即与不良结局相关;无gain(1q)者中位OS超过9年。
- 非克隆性gain(11q)且无原发IGH易位患者中,1q21≥4拷贝(而非3拷贝)对结局有显著不良影响。
- 克隆性gain(11q)且无原发IGH易位病例与超二倍体、CD56和CD117共表达、男性及IgG亚型相关。
- t(14;16)亚组中观察到早期四倍体、浆细胞白血病和女性 predominance。
临床怎么用
- MM预后评估应结合原发遗传事件亚组解读1q21拷贝数。
- 对克隆性gain(11q)且无原发IGH易位者,3拷贝1q21即应视为不良预后标志。
- 对非该亚组患者,1q21≥4拷贝才具有显著不良预后意义。
局限性
- 本研究为回顾性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hyperdiploidy (HRD) and specific immunoglobulin heavy locus (IGH) translocations are primary chromosomal abnormalities (CA) in multiple myeloma (MM). In this retrospective study of 794 MM patients we aimed to investigate clinical features and common CA including gain(1q) in separate subgroups defined by primary CA. In the entire group, we confirmed that gain(1q) was associated with short time to next treatment and adverse overall survival (OS). The impact was worse for four or more copies of 1q21 as compared to three copies. However, in a subgroup of patients with clonal gain(11q) and without known primary IGH translocations (CG11q), already three copies of 1q21 were associated with a poor outcome; in the absence of gain(1q), patients in this subgroup had a remarkably long median OS of more than nine years. These cases were associated with HRD, coexpression of CD56 and CD117, male gender, and IgG subtype. In non-CG11q patients, four or more copies of 1q21 (but not three copies) had a significant adverse impact on outcome. Several associations with CA and clinical findings were observed for the defined subgroups. As an example, we found a predominance of early tetraploidy, plasma cell leukemia, and female gender in the t(14;16) subgroup. Our results underscore the importance of subgrouping in MM.
引用
- Locher M, Steurer M, Jukic E, et al. The prognostic value of additional copies of 1q21 in multiple myeloma depends on the primary genetic event. Am J Hematol. 2020. PMID: 32936982. doi:10.1002/ajh.25994
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。